@2022 end 5% month-over-month revenue increase from 35 sitesLatest quarter 2022 was all about growing recurring revenue with TULSA-PRO treatments in USA. The revenue growth rate reached 5% per month. No capital equipment sales last Q due to on-going COVID issues in China & Japan.
They expect the 5% per month revenue growth rate for TULSA to be maintaned or likely increase in 2023 as urologiets gain experience and more sites are installed. The time required to install new sites is expected to come down significantly.
Armed now with data from both 2021 and 2022 they will be applying for permanent CPT reimbursement. The result of that applicaition should be known in the first days of June, 2023